Consensus Collegium Pharmaceutical, Inc.

Equities

COLL

US19459J1043

Delayed Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
34.25 ^USD	+1.27%		+5.48%	+11.27%

May. 13	Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program	MT
May. 10	Needham Downgrades Collegium Pharmaceutical to Hold From Buy	MT

Evolution of the average Target Price on Collegium Pharmaceutical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

4e522caa295153f6292c65059b7.-tb2ZXyE0cUd-cCbClDfRCeqAGtxF5EZoyGXQ8hqdqQ.j7uiCxe0t5QrpofTJyrvAmbLVF4iJ8dz0RP9cos_H_aZvKwEEtaSqkSmtw~e9462d64181fc846912c71509deb16e4

Analyst Recommendations on Collegium Pharmaceutical, Inc.

Needham Downgrades Collegium Pharmaceutical to Hold From Buy	May. 10	MT
Piper Downgrades Collegium Pharmaceutical to Neutral From Overweight, Price Target at $39	May. 10	MT
Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating	Feb. 26	MT
Truist Adjusts Price Target on Collegium Pharmaceutical to $40 From $37, Maintains Buy Rating	Feb. 26	MT
Truist Adjusts Collegium Pharmaceutical's Price Target to $37 From $31, Keeps Buy Rating	Jan. 04	MT
Jefferies Downgrades Collegium Pharmaceutical to Hold From Buy, Raises Price Target to $37 From $30	Jan. 04	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $36 From $35, Maintains Buy Rating	23-08-25	MT
Jefferies Assumes Collegium Pharmaceutical at Buy With $30 Price Target	23-05-02	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $35 From $34, Maintains Buy Rating	23-01-05	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $34 From $36, Maintains Buy Rating	22-11-04	MT
HC Wainwright Downgrades Collegium Pharmaceutical to Neutral From Buy	22-08-08	MT
Needham Adjusts Collegium Pharmaceutical's Price Target to $36 From $34, Keeps Buy Rating	22-04-06	MT
Piper Sandler Adjusts Collegium Pharmaceutical's Price Target to $42 From $36, Reiterates Overweight Rating	22-02-22	MT
Needham Adjusts Collegium Pharmaceutical's Price Target to $34 From $28, Reiterates Buy Rating	22-02-15	MT
HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $29 From $26, Reiterates Buy Rating	22-02-15	MT
Cantor Fitzgerald Upgrades Collegium Pharmaceutical to Overweight From Neutral; Price Target is $26	22-02-15	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $28 from $26, Keeps Buy Rating	21-11-15	MT
HC Wainwright Adjusts Collegium Pharmaceutical PT to $26 From $28, Maintains Buy Rating	21-11-05	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $26 From $32, Maintains Buy Rating	21-11-05	MT
COLLEGIUM PHARMACEUTICAL : Cantor Fitzgerald Downgrades Collegium Pharmaceutical to Neutral from Overweight, Adjusts Price Target to $22 from $30	21-08-06	MT
COLLEGIUM PHARMACEUTICAL : HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $28 From $33, Maintains Buy Rating	21-08-06	MT
COLLEGIUM PHARMACEUTICAL : HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $29 from $31, Maintains Buy Rating	20-11-09	MT